ArticleCancer2010

Maintenance therapy with low-dose azacitidine after allogeneic hematopoietic stem cell transplantation for recurrent acute myelogenous leukemia or myelodysplastic syndrome: a dose and schedule finding study.

Marcos de Lima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.